Journal de la maladie d'Alzheimer et du parkinsonisme

Abstrait

The Emergency of Nutraceutical Compounds in the Preventive Medicine Scenario. Potential for Treatment of Alzheimer's Disease and Other Chronic Disorders

Víctor Andrade, Leonardo Guzmán-Martínez, Nicole Cortés, Andrea González, Gonzalo Farías and Ricardo B Maccioni

Evidence-based Nutraceutical Compounds (EBNC), containing bioactive principles of demonstrated efficacy and health security are opening solutions for a modern preventive medicine, and as potential solutions for many chronic diseases of the human beings. EBNC contain bioactive components of the human diet that can be used for the prevention or treatment of a disease. They are obtained through rigorous processes of extraction from natural resources and Good Manufacturing Practices (GMP) regulations, and exhibit sound preclinical studies published in high impact medical journals, and double-blind placebo-controlled clinical trials. Are these compounds significantly more effective than alternative medicines? EBNC rely on some of the major advances in molecular genetics, epitranscriptomics, molecular biology and modern pharmacology. They are certainly opening a solid pathway in benefit of human health and the welfare of mankind.